These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 16270194

  • 1. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
    Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.
    Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
    [Abstract] [Full Text] [Related]

  • 2. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
    Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM.
    Biochem J; 2001 Oct 01; 359(Pt 1):77-87. PubMed ID: 11563971
    [Abstract] [Full Text] [Related]

  • 3. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
    Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP.
    Kidney Int; 1998 Mar 01; 53(3):631-8. PubMed ID: 9507208
    [Abstract] [Full Text] [Related]

  • 4. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
    Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, Fujinaga Y, Yokoi H, Tanaka I, Nakao K.
    Clin Exp Nephrol; 2003 Mar 01; 7(1):33-40. PubMed ID: 14586741
    [Abstract] [Full Text] [Related]

  • 5. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
    Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG.
    J Am Soc Nephrol; 2000 Jan 01; 11(1):25-38. PubMed ID: 10616837
    [Abstract] [Full Text] [Related]

  • 6. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.
    Zhou G, Li C, Cai L.
    Am J Pathol; 2004 Dec 01; 165(6):2033-43. PubMed ID: 15579446
    [Abstract] [Full Text] [Related]

  • 7. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
    Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR.
    J Biol Chem; 1999 Feb 26; 274(9):5830-4. PubMed ID: 10026205
    [Abstract] [Full Text] [Related]

  • 8. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
    Twigg SM, Cao Z, MCLennan SV, Burns WC, Brammar G, Forbes JM, Cooper ME.
    Endocrinology; 2002 Dec 26; 143(12):4907-15. PubMed ID: 12446618
    [Abstract] [Full Text] [Related]

  • 9. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
    Riser BL, Cortes P.
    Ren Fail; 2001 Dec 26; 23(3-4):459-70. PubMed ID: 11499561
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes.
    Fuchshofer R, Birke M, Welge-Lussen U, Kook D, Lütjen-Drecoll E.
    Invest Ophthalmol Vis Sci; 2005 Feb 26; 46(2):568-78. PubMed ID: 15671284
    [Abstract] [Full Text] [Related]

  • 11. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
    McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM.
    Endocrinology; 2004 Dec 26; 145(12):5646-55. PubMed ID: 15345671
    [Abstract] [Full Text] [Related]

  • 12. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S, Denichilo M, Brubaker C, Hirschberg R.
    Kidney Int; 2001 Jul 26; 60(1):96-105. PubMed ID: 11422741
    [Abstract] [Full Text] [Related]

  • 13. Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats.
    Liu N, Makino T, Nogaki F, Kusano H, Suyama K, Muso E, Honda G, Kita T, Ono T.
    Am J Physiol Renal Physiol; 2004 Oct 26; 287(4):F612-20. PubMed ID: 15172885
    [Abstract] [Full Text] [Related]

  • 14. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.
    Weston BS, Wahab NA, Mason RM.
    J Am Soc Nephrol; 2003 Mar 26; 14(3):601-10. PubMed ID: 12595495
    [Abstract] [Full Text] [Related]

  • 15. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
    Umezono T, Toyoda M, Kato M, Miyauchi M, Kimura M, Maruyama M, Honma M, Yagame M, Suzuki D.
    J Nephrol; 2006 Mar 26; 19(6):751-7. PubMed ID: 17173248
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, Sawai K, Yoshioka T, Saito Y, Ogawa Y, Kuwabara T, Sugawara A, Nakao K.
    Kidney Int; 2008 Feb 26; 73(4):446-55. PubMed ID: 18075496
    [Abstract] [Full Text] [Related]

  • 17. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
    Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.
    Diabetes; 2006 Jun 26; 55(6):1678-85. PubMed ID: 16731830
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U.
    Diabetes; 1997 Nov 26; 46(11):1881-7. PubMed ID: 9356040
    [Abstract] [Full Text] [Related]

  • 19. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M, Xu ZG, Tung D, Lanting L, Natarajan R.
    FASEB J; 2007 Oct 26; 21(12):3355-68. PubMed ID: 17554073
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y, Wang B, Keum JS, Jaffa AA.
    Am J Physiol Renal Physiol; 2005 Mar 26; 288(3):F483-92. PubMed ID: 15692059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.